Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N L Michael

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
The Journal of Infectious Diseases|October 21, 1998
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infectionL D Loomis-Price, J H Cox, J R Mascola, et al.
The Journal of Infectious Diseases|July 7, 2000
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infectionA Brambilla, C Villa, G Rizzardi, et al.
Virology|December 9, 2000
Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reactionM O Salminen, P K Ehrenberg, J R Mascola, et al.
Journal of Clinical Microbiology|July 16, 1999
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypesN L Michael, S A Herman, S Kwok, et al.
Journal of Virology|February 11, 1999
CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor functionR Mariani, S Wong, L C Mulder, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infectionJ H Kim, J R Mascola, S Ratto-Kim, et al.
Tissue Antigens|March 4, 2009
HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic clusterG H Kijak, A M Walsh, R N Koehler, et al.
Science (New York, N.Y.)|December 4, 1998
Genetic acceleration of AIDS progression by a promoter variant of CCR5M P Martin, M Dean, M W Smith, et al.
Journal of Virology|November 13, 1998
Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cellsS S Frankel, R M Steinman, N L Michael, et al.
Annals of Internal Medicine|November 6, 2001
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient dataJ P Ioannidis, P S Rosenberg, J J Goedert, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
The Journal of Infectious Diseases|October 21, 1998
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infectionL D Loomis-Price, J H Cox, J R Mascola, et al.
The Journal of Infectious Diseases|July 7, 2000
Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infectionA Brambilla, C Villa, G Rizzardi, et al.
Virology|December 9, 2000
Construction and biological characterization of infectious molecular clones of HIV-1 subtypes B and E (CRF01_AE) generated by the polymerase chain reactionM O Salminen, P K Ehrenberg, J R Mascola, et al.
Journal of Clinical Microbiology|July 16, 1999
Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypesN L Michael, S A Herman, S Kwok, et al.
Journal of Virology|February 11, 1999
CCR2-64I polymorphism is not associated with altered CCR5 expression or coreceptor functionR Mariani, S Wong, L C Mulder, et al.
AIDS Research and Human Retroviruses|August 4, 2001
Selective increases in HIV-specific neutralizing antibody and partial reconstitution of cellular immune responses during prolonged, successful drug therapy of HIV infectionJ H Kim, J R Mascola, S Ratto-Kim, et al.
Tissue Antigens|March 4, 2009
HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic clusterG H Kijak, A M Walsh, R N Koehler, et al.
Science (New York, N.Y.)|December 4, 1998
Genetic acceleration of AIDS progression by a promoter variant of CCR5M P Martin, M Dean, M W Smith, et al.
Journal of Virology|November 13, 1998
Neutralizing monoclonal antibodies block human immunodeficiency virus type 1 infection of dendritic cells and transmission to T cellsS S Frankel, R M Steinman, N L Michael, et al.
Annals of Internal Medicine|November 6, 2001
Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient dataJ P Ioannidis, P S Rosenberg, J J Goedert, et al.
Pageof 6